Рет қаралды 915
The human body provides a perfect cell culture environment, an optimal flow of nutrients in and waste out. Cell therapy developers can put that kind of precision to work in an automated cell therapy manufacturing process, thanks to the hollow-fiber perfusion technology available in the Quantum Flex Cell Expansion System from Terumo Blood and Cell Technologies. We’re delivering the next generation of cell expansion - where cells thrive.
#celltherapy #cellandgenetherapy #biotech #celltherapyautomation #stemcells #carttherapy
Learn more and download resources at: reach.terumo-b...
2022?_ga=2.230246300.1063627350.1678114207-312955997.1674227958
More information on Quantum Flex
Hollow-Fiber Technology - Continuous perfusion over small distances means yields with greater than 90% viability while maintaining target phenotypes.*
Versatility and Scalability - Scalability from process development to commercial manufacturing, while supporting both autologous and allogeneic applications for a variety of adherent and suspension cell types.
Low Seeding - Low amounts of starting material mean a reduction or elimination of manual preculture.
High Yield in Low Volumes - Billions of suspension cells and hundreds of millions of adherent cells or more, harvested in a volume less than 1 L for simplified downstream processing.*
Data Integrity and GMP - Maintain data integrity and facilitate cGMP compliance including 21 CFR Part 11/Annex 11 regulations.
Follow us:
LinkedIn - / terumo-bct
Twitter - / terumobct
Facebook - / terumobct
*Data on file at Terumo Blood and Cell Technologies. It is the responsibility of the user to validate the safety and efficacy of the expanded cells for their intended application. Performance varies by user and is dependent on customer processes and materials